Flagship VentureLabs VI LLC — SEC Form 4 filings

SEC reporting owner CIK 1725008. 1 Form 4 filing on record with FilingPulse; latest filed 2026-03-02.

Transaction summary — filings shown

Covers all 1 filing on record, filed 2026-03-02 to 2026-03-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Generate Biomedicines, Inc. (GENB)10% owner13 legs · 4,687,500 sh · $75,000,00016

Form 4 filings — Flagship VentureLabs VI LLC

FiledFormIssuerReported transactionsSource
2026-03-024Generate Biomedicines, Inc. (GENB)
jointly with AFEYAN NOUBAR, Flagship Pioneering Fund VI, L.P., Flagship Pioneering Fund VII, L.P., Nutritional Health LTP Fund, L.P., Flagship Pioneering Special Opportunities Fund II, L.P., FPN II, L.P.
Conversion (C): 12,723,940 · Conversion (C): 13,702,224 · Conversion (C): 987,491 · Conversion (C): 2,777,752 · Conversion (C): 2,777,752 · Purchase (P): 1,562,500 @ $16 · +13 moreEDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1725008 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →